[Infection in Children with Acute Myeloid Leukemia in the Intensive Chemotherapy Period]
Kai Lan Chen1, Hao Xiong1, Jian Xin Li1
1Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, Hubei Province, China.
Insights
Children with acute myeloid leukemia (AML) experience high infection rates during chemotherapy. Bloodstream infections, often caused by Gram-negative bacteria, are a major concern, necessitating antifungal use.
Area of Science:
- Pediatric Oncology
- Infectious Diseases
- Hematology
Background:
- Acute myeloid leukemia (AML) is a serious hematologic malignancy in children.
- High-intensity chemotherapy regimens are crucial for AML treatment but significantly increase infection risk.
- Understanding infection patterns is vital for improving outcomes in pediatric AML patients.
Purpose of the Study:
- To analyze the clinical characteristics of infections in pediatric AML patients undergoing intensive chemotherapy.
- To identify common pathogens and infection sites during chemotherapy.
- To provide data for optimizing infection prevention and control strategies.
Main Methods:
- Retrospective analysis of 56 pediatric AML patients treated between January 2016 and August 2019.
- Evaluation of infection rates, causative pathogens, and common infection locations during induction and consolidation chemotherapy.
- Analysis of infection-related mortality.
Main Results:
- A high overall infection rate (93.4%-96.4%) was observed in pediatric AML patients.
- The average rate of severe infections was 16.0%, with bloodstream infections being most common, primarily caused by Gram-negative bacteria.
- Fungal infections occurred in 35.7% of patients, and infection-related mortality was 10.7%.
Conclusions:
- Pediatric AML patients face a substantial risk of infection throughout chemotherapy.
- Bloodstream infections represent a significant cause of severe illness and mortality.
- Proactive use of antifungal agents is recommended to mitigate fungal infections in this vulnerable population.
Objective:
To investigate the clinical characteristics of infection in children with acute myeloid leukemia (AML) after high intensive chemotherapy, so as to provide reference for prevention and control of infection.
Methods:
56 children diagnosed as acute myeloid leukemia in our hospital from January 2016 to August 2019 were enrolled and retrospectively analyzed, the infection rate, pathogens of disease and common location of infection during the induction and consolidation period were analyzed.
Results:
The total infection rate of the patients was 93.4%-96.4%, the average of serious infection rate was 16.0%(11.3%-19.6%), and the infection related mortality was 10.7%. Fever of unknown cause was the main reason of infection, while blood flow infections were the most common in severe infection, which were mainly caused by Gramnegative bacteria. The rate of fungal infection was 35.7% during chemotherapy.
Conclusion:
Children with AML shows a high incidence of infection in each stage of chemotherapy. The serious illness caused by blood flow infection and take antifungal drugs to reduce the occurrence of fungal infection in AML patients should be paid attention.
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis I: Introduction
Differentiation of Common Myeloid Progenitor Cells


